BSE - Delayed Quote INR

Shree Ganesh Remedies Limited (SGRL.BO)

738.30
-18.15
(-2.40%)
At close: 3:29:56 PM GMT+5:30
Loading Chart for SGRL.BO
  • Previous Close 756.45
  • Open 762.05
  • Bid 735.10 x --
  • Ask 737.50 x --
  • Day's Range 731.20 - 773.95
  • 52 Week Range 617.20 - 950.00
  • Volume 5,671
  • Avg. Volume 6,681
  • Market Cap (intraday) 9.478B
  • Beta (5Y Monthly) 0.41
  • PE Ratio (TTM) 33.08
  • EPS (TTM) 22.32
  • Earnings Date May 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 7, 2023
  • 1y Target Est --

Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India. It provides anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, anti-fungal, anti-histamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. The company also offers fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals, including cyclopropanecarboxaldehyde, hexamethylendichloride, octamethylendiamine, and suberonitrile for pharmaceutical, agricultural, and various chemical applications. In addition, it is involved in customized chemistry development and manufacturing; assets and infrastructure; and customized process of pharmaceutical chemicals. The company also exports its products. It serves various industries, including pharmaceuticals, biotechnology, medical devices, and others. The company was incorporated in 1995 and is headquartered in Ankleshwar, India.

www.ganeshremedies.com

139

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SGRL.BO

View More

Performance Overview: SGRL.BO

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SGRL.BO
16.30%
S&P BSE SENSEX (^BSESN)
4.08%

1-Year Return

SGRL.BO
12.67%
S&P BSE SENSEX (^BSESN)
11.25%

3-Year Return

SGRL.BO
12.67%
S&P BSE SENSEX (^BSESN)
54.05%

5-Year Return

SGRL.BO
12.67%
S&P BSE SENSEX (^BSESN)
161.32%

Compare To: SGRL.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGRL.BO

View More

Valuation Measures

Annual
As of 5/13/2025
  • Market Cap

    9.71B

  • Enterprise Value

    9.84B

  • Trailing P/E

    33.94

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.96

  • Price/Book (mrq)

    7.29

  • Enterprise Value/Revenue

    8.07

  • Enterprise Value/EBITDA

    20.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    23.34%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.22B

  • Net Income Avi to Common (ttm)

    284.69M

  • Diluted EPS (ttm)

    22.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    212.74M

  • Total Debt/Equity (mrq)

    25.42%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: SGRL.BO

View More

Company Insights: SGRL.BO

Research Reports: SGRL.BO

View More

People Also Watch